ASSESSMENT OF RENAL FUNCTIONAL RESERVE AGAINST THE BACKGROUND OF ANTIAGGREGANT THERAPY IN STAGE II-III CHRONIC KIDNEY DISEASE

Abstract

The article presents the results of a study to evaluate the comparative effectiveness of the antiaggregant drugs dipyridamole and alltrombosepine on the functional kidney reserve in 50 patients at the early stage of chronic kidney disease. The study showed that long-term use of alltrombosepine improves the functional reserve of the kidneys. Thus, our studies have once again confirmed that the widely used antiaggregant, made from local raw materials, alltrombosepine is not inferior to dipyridamole, which is used in chronic kidney disease.